{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":".667","upperLimit":".842","value":".765"}]}]}],"denomUnitsSelected":"Lesions","denoms":[{"counts":[{"groupId":"OG000","value":"89"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"104"}],"units":"Lesions"}],"description":"Sensitivity or True Positive Rate (TPR) for OTL38 used with fluorescent light in FAS subjects, defined as the proportion of fluorescent light positive primary nodules and synchronous lesions that are histologically confirmed to be cancer relative to the total number of primary nodules and synchronous lesions confirmed to be cancer.","dispersionType":"95% Confidence Interval","groups":[{"description":"The full analysis set will include subjects exposed to OTL38 and randomized to undergo NIR fluorescent imaging (OTL38+Imaging) who were evaluated under both normal light and NIR fluorescent light imaging","id":"OG000","title":"Fully Analysis Set (FAS)"}],"paramType":"NUMBER","populationDescription":"Total number of Subjects with Evaluated Tissues","reportingStatus":"POSTED","timeFrame":"1 day","title":"Sensitivity for Cancerous Primary Nodules and Synchronous Lesions in FAS Subjects","type":"SECONDARY","typeUnitsAnalyzed":"Lesions","unitOfMeasure":"proportion of lesions"}